Health Care & Life Sciences » Pharmaceuticals | Hainan Haiyao Co. Ltd.

Hainan Haiyao Co. Ltd. A | Mutual Funds

Mutual Funds that own Hainan Haiyao Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Lion Value Growth Fund
4,261,135
0.39%
-500,084
1.61%
12/31/2017
4,200,000
0.38%
-3,150,000
0.75%
12/31/2017
Nanfang CSI 500 ETF
3,380,797
0.31%
-240,400
0.16%
12/31/2017
1,432,328
0.13%
929,465
1.83%
12/31/2017
1,255,756
0.11%
-44,700
0.56%
12/31/2017
574,395
0.05%
-574,300
1.64%
12/31/2017
509,296
0.05%
68,900
0.36%
12/31/2017
479,740
0.04%
-97,500
0.41%
12/31/2017
GF CSI 500 ETF
296,566
0.03%
-39,200
0.18%
12/31/2017
274,239
0.03%
-115,400
0.1%
12/31/2017

About Hainan Haiyao Co.

View Profile
Address
No. 192 Nanhai Avenue
Haikou Hainan 570311
China
Employees -
Website http://www.haiyao.com.cn
Updated 07/08/2019
Hainan Haiyao Co., Ltd. engages in the research, development, manufacture and sale of medicines and medical instrument. Its products consist of six categories, including cephalosporin series, stomach and intestine medicines, anti-tumor medicines, cochlear implant series, bulk drugs and intermediate series. The company was founded in 1965 and is headquartered in Haikou, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.